Rang	Name	Position
1	Mr. Joseph P. Hagan M.B.A.	CEO & Director
2	Dr. Preston S. Klassen M.D., M.H.S.	President, Head of Research & Development and Director
3	Ms. Crispina Calsada CPA	Chief Financial Officer
4	Mr. Daniel J. Penksa	VP of Finance & Controller
5	Mr. Christopher Ray Aker J.D.	Senior VP, General Counsel & Corporate Secretary
6	Dr. Claire Susan Padgett M.S., M.T., Ph.D.	Senior Vice President of Clinical Operations
7	Dr. Rekha Garg M.D., M.S.	Chief Medical Officer
8	Mr. Edmund Lee Ph.D.	Vice President of Translational Medicine

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	6,02%	34,03 Mio. USD
2	Vivo Capital, LLC	3,89%	22,00 Mio. USD
3	Geode Capital Management, LLC	1,88%	10,62 Mio. USD
4	State Street Corp	1,50%	8,46 Mio. USD
5	Northern Trust Corp	0,64%	3,63 Mio. USD
6	Victory Capital Management Inc.	0,56%	3,16 Mio. USD
7	Wells Fargo & Co	0,30%	1,67 Mio. USD
8	UBS Group AG	0,27%	1,51 Mio. USD
9	Susquehanna International Group, LLP	0,22%	1,23 Mio. USD
10	Bank of New York Mellon Corp	0,22%	1,22 Mio. USD
11	Citadel Advisors Llc	0,21%	1,21 Mio. USD
12	Renaissance Technologies Corp	0,21%	1,21 Mio. USD
13	Nuveen, LLC	0,12%	0,70 Mio. USD
14	Morgan Stanley - Brokerage Accounts	0,11%	0,63 Mio. USD
15	JPMorgan Chase & Co	0,11%	0,61 Mio. USD
16	Barclays PLC	0,09%	0,53 Mio. USD
17	Rhumbline Advisers	0,08%	0,47 Mio. USD
18	ING Investment Management LLC	0,06%	0,35 Mio. USD
19	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	0,06%	0,31 Mio. USD
20	LPL Financial Corp	0,05%	0,31 Mio. USD